Ypsomed Digital Health
Managing their own disease treatment is complex for many patients. Different treatment regimes, misinformation about the condition, and emotional distress with self-injection are only some of the factors that lead to poor therapy adherence and diminished treatment effectiveness.
We strongly believe that multifactorial support is needed to aid patients in managing their chronic condition.
We provide pharmaceutical companies with integrated digital solutions by combining connected injection devices with digital patient solutions. Ypsomed Digital Health helps facilitate therapy management for patients and generates business-changing insights for pharmaceutical companies.
-
More
Connected devices:
- Support patients in self-medication
- Capture accurate and unbiased data
-
More
Mobile app:
- Supports patients during their disease journey
- Allows for data-driven interventions due to early identification of patients' specific needs
-
More
Data analytics:
- Unlocks accurate and unbiased real world data at scale by capturing therapy-relevant data
- Enables evidence-based and continuous care by connecting patients to their stakeholders
Seamlessly integrated connected injection devices with digital therapy management.
Stay connected with us
Contact us to find out more on how our services can enhance your business. Start your Ypsomed journey today.
Latest Insights
Stay up to date on our recent news and publications here.
Burgdorf – Ypsomed (SIX: YPSN) will expand its offering of digital health solutions together with S3 Connected Health in the future. S3 Connected Health, headquartered in Dublin, Ireland is a specialist digital health partner for life science companies.
Burgdorf – Ypsomed (SIX: YPSN) and Sidekick Health today announced a collaboration to extend Ypsomed’s device and SmartServices offering by implementing a self-injection module in Sidekick’s proven digital therapeutics solution.
